A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance

  • Hao Zheng, Shilin Li, Liang Ma, Ling Cheng, Chongyang Deng, Zhizhi Chen, Caifeng Xie, Mingli Xiang, Wei Jiang, Lijuan Chen
  • European Journal of Pharmacology, June 2011, Elsevier
  • DOI: 10.1016/j.ejphar.2011.03.033

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Liang Ma